Munafa Stock Market Course + Intraday & FNO calls 
APLLTD NEWS why is Alembic Pharmaceuticals Limited price falling or rising
APLLTD NEWS reasons for why stock price of Alembic Pharmaceuticals Limited is falling or rising
APLLTD Alembic Pharmaceuticals is falling or rising technical reasons
Technical analysis forecast for Alembic Pharmaceuticals Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Alembic Pharmaceuticals APLLTD at this time. Stock is falling and might fall more.
It appears as if Alembic Pharmaceuticals APLLTD gave a large move recently.
Stock of Alembic Pharmaceuticals (APLLTD) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, stock might keep falling and stock might move lower...
My analysis of Alembic Pharmaceuticals is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Alembic Pharmaceuticals stays below 855.5, but if it comes above 855.5, then a intra day buy could be more profitable.
If you take a sell trade below 855.5, then use 855.5 as stoploss and 828.1 as target. However if you take a buy trade in Alembic Pharmaceuticals, then use 855.5 as stoploss and 878.22 as target.
APLLTD Alembic Pharmaceuticals is falling or rising NEWS fundamental reasons
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 18, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Travoprost Ophthalmic Solution". - NEWS as on 2025-12-18
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company - NEWS as on 2025-12-16
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication-Special Window for re-lodgement of transfer requests of physical shares. - NEWS as on 2025-12-16
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange about a Copy of Newspaper Publication related to notice of loss of equity share certificate. - NEWS as on 2025-12-15
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 11, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, 0.5%/0.3%". - NEWS as on 2025-12-11
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication related to notice of loss of equity share certificate. - NEWS as on 2025-12-10
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange about Schedule of meet of one on one meeting with ICICI Prudential - NEWS as on 2025-12-05
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange about Schedule of meet of one on one meet with investors - NEWS as on 2025-12-05
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange about change in Management - NEWS as on 2025-12-02
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 15, 2025, titled "Alembic Pharmaceuticals Limited announces USFDA Final Approval for Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg". - NEWS as on 2025-11-17
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 13, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dexlansoprazole Delayed-Release Capsules, 30 mg and 60 mg.". - NEWS as on 2025-11-14
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange about Transcript - NEWS as on 2025-11-11
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication. - NEWS as on 2025-11-11
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 07, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg.". - NEWS as on 2025-11-07
More announcements and NEWS
APLLTD Alembic Pharmaceuticals Limited current price & indicator signals
Recent prices of APLLTD Alembic Pharmaceuticals Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 22 Mon Dec 2025 | 853.75 | 850.00 to 861.95 | -0.72% | 0.7 times |
| 19 Fri Dec 2025 | 859.90 | 837.90 to 865.40 | 1.37% | 1.01 times |
| 18 Thu Dec 2025 | 848.25 | 835.50 to 853.00 | 0.14% | 1.97 times |
| 17 Wed Dec 2025 | 847.10 | 840.10 to 852.80 | -0.01% | 0.43 times |
| 16 Tue Dec 2025 | 847.15 | 842.45 to 872.30 | -2.03% | 0.84 times |
| 15 Mon Dec 2025 | 864.70 | 862.95 to 878.85 | -1.39% | 0.92 times |
| 12 Fri Dec 2025 | 876.90 | 874.10 to 890.65 | -0.93% | 0.77 times |
| 11 Thu Dec 2025 | 885.10 | 880.25 to 894.50 | 0.2% | 0.69 times |
| 10 Wed Dec 2025 | 883.35 | 878.60 to 897.15 | -0.39% | 0.41 times |
| 09 Tue Dec 2025 | 886.85 | 850.50 to 894.20 | 0.71% | 0.76 times |
| 08 Mon Dec 2025 | 880.60 | 870.00 to 903.95 | -2.13% | 2.19 times |
| 05 Fri Dec 2025 | 899.80 | 891.10 to 905.00 | -0.22% | 0.96 times |
Videos related to: APLLTD NEWS why is Alembic Pharmaceuticals Limited price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
